{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:49:18Z","timestamp":1785750558102,"version":"3.56.0"},"reference-count":42,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,8,3]]},"DOI":"10.1080\/13543776.2026.2701884","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:36:54Z","timestamp":1783604214000},"page":"695-712","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Recent patent landscape of ASK1 inhibitors: spotlight on 2-(1-isopropyl-4H-1,2,4-triazole-3-yl) pyridine as a privileged scaffold"],"prefix":"10.1080","volume":"36","author":[{"given":"Yash Kumar","family":"Gaur","sequence":"first","affiliation":[{"name":"ISF College of Pharmacy","place":["Moga, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyanshi","family":"Thakur","sequence":"additional","affiliation":[{"name":"ISF College of Pharmacy","place":["Moga, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Nag","sequence":"additional","affiliation":[{"name":"ISF College of Pharmacy","place":["Moga, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalicharan","family":"Sharma","sequence":"additional","affiliation":[{"name":"ISF College of Pharmacy","place":["Moga, India"]},{"name":"Graphic Era Hill University","place":["Dehradun, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5296.90"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1200"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a002947"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.992302"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.88.434"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10080"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.9.2596"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.6.2198-2208.2000"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/embo-reports\/kve046"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000100665.67510.F5"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98446"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810124"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00208.2016"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728220902980249"},{"issue":"9","key":"e_1_3_5_17_1","first-page":"2785","article-title":"ASK1 inhibits proliferation and migration of lung cancer cells via inactivating TAZ","volume":"10","author":"Han T","year":"2020","unstructured":"Han T, Gao J, Wang L, et al. ASK1 inhibits proliferation and migration of lung cancer cells via inactivating TAZ. Am J Cancer Res. 2020;10(9):2785.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3432"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400072"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.12.041"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.08.027"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113482"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.027"},{"key":"e_1_3_5_24_1","unstructured":"Notte G. Apoptosis signal-regulating kinase inhibitor. Google Patents. 2016."},{"key":"e_1_3_5_25_1","unstructured":"Rowbottom MW. Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds. Google Patents. 2022."},{"key":"e_1_3_5_26_1","unstructured":"Corkey B Graupe M Koch K et al. Apoptosis signal-regulating kinase inhibitors. Google Patents. 2021."},{"key":"e_1_3_5_27_1","unstructured":"Kim D Kim S Yoo J et al. Novel n-(isopropyl-triazolyl) pyridinyl)-heteroaryl-carboxamide derivatives and use thereof. Google Patents. 2022."},{"key":"e_1_3_5_28_1","unstructured":"Jin B Dong Q Hung G Apoptosis signal-regulating kinase inhibitors and uses thereof. Google Patents. 2021."},{"key":"e_1_3_5_29_1","unstructured":"De Turiso FGL Himmelbauer M Luzzio MJ ASK1 inhibiting agents. Google Patents. 2021."},{"key":"e_1_3_5_30_1","unstructured":"Jin B inventor; FRONTHERA U.S. PHARMACEUTICALS LLC assignee. PYRIDINYL BASED APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS patent WO2018151830A1. 2018."},{"key":"e_1_3_5_31_1","unstructured":"Martin RW Inventor; sidecar Therapeutics Inc. assignee. Apoptosis signal-regulating kinase 1 (ask 1) inhibitor compounds patent WO2019070742A1. 2019."},{"key":"e_1_3_5_32_1","unstructured":"Yingzi X Halcomb R Kirschberg TA et al. Tricyclic ASK1 inhibitors. Google Patents. 2021."},{"key":"e_1_3_5_33_1","unstructured":"Wu C Yu T Li N et al. Pyridine derivative as ASK1 inhibitor and preparation method and use thereof. Google Patents. 2021."},{"key":"e_1_3_5_34_1","unstructured":"Amantini D Mesic M Saxty G et al. Pyrrolopyrimidine and pyrrolopyridine derivatives. Google Patents. 2022."},{"key":"e_1_3_5_35_1","unstructured":"Chang E Gwaltney SL Vassar A Apoptosis signal-regulating kinase 1 inhibitors. Google Patents. 2012."},{"key":"e_1_3_5_36_1","unstructured":"Chang E Duong T Hirano T et al. Apoptosis signal-regulating kinase 1 inhibitors. Google Patents. 2009."},{"key":"e_1_3_5_37_1","unstructured":"Rai SK Patil RI Roy SS et al. Novel apoptosis signal-regulating kinase 1 inhibitors. Google Patents. 2022."},{"key":"e_1_3_5_38_1","unstructured":"Liu LZ Wang X Wiley MR. Imidazolidine compounds. Google Patents. 2021."},{"key":"e_1_3_5_39_1","unstructured":"Liu LZ Zhang H Wang X et al. Cyclobutyl-imidazolidinone compounds. Google Patents. 2019."},{"key":"e_1_3_5_40_1","unstructured":"Xu X Oxazole and thiazole derivatives as inhibitors of ask1. Google Patents. 2021."},{"key":"e_1_3_5_41_1","unstructured":"Notte G inventor; Gilead Sciences Inc assignee. APOPTOSIS SIGNAL-REGULATING KNASE INHIBITORS patent US20140179663A1. 2014."},{"key":"e_1_3_5_42_1","unstructured":"Kim D Kim S Yoo J et al. Novel (isopropyl-triazolyl) pyridinyl-substituted benzooxazinone or benzothiazinone derivatives and use thereof. Google Patents. 2022."},{"key":"e_1_3_5_43_1","unstructured":"Lei H Liu G Tian Y et al. Isoquinolin and naphthydrin compounds. Google Patents. 2021."},{"key":"e_1_3_5_44_1","unstructured":"Smith CR Chapman J. ASK1 isoindolin-1-one inhibitors and methods of use thereof. Google Patents. 2020."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2701884","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13543776.2026.2701884","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2701884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:33:50Z","timestamp":1785749630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2701884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"alternative-id":["10.1080\/13543776.2026.2701884"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2701884","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}